Commure builds an AI-driven software platform for healthcare operations — from ambient clinical documentation to staff and revenue workflows. Backed by General Catalyst; merged with Athelas.
Healthcare📍 Mountain View, CA
Current Valuation
$6.0B
as of 2024
UNICORN
QL Price
$7.0B
0% vs last round
QuantLogix's current estimate for Commure, published 2026-09-21 — in line with the last disclosed round of $7.0B (2026-05).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round
$7.0B
2026-05
weight 0.76
Secondary market print
$7.0B
2026-06-27
weight 0.6
How this price has held up
No round has priced for Commure since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-21 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Commure, 2026-09-21 (7dd1562a14a88579).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Commure going public?
No. Commure is private and has not filed to go public. There is no S-1 on file.
What is Commure's valuation in 2026?
Commure is valued at $6.0B as of 2024. That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Commure filed an S-1?
No public S-1 is on file for Commure.
Can you buy Commure stock?
No. Commure is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Commure on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
HQ
Mountain View, CA
IPO Status
private
Fundraising Status
private
Secondary Market
Implied price / share
$27.57
Open interest
11
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Vertical Intelligence — AI / ML
Open models
0
Downloads (30d)
0
across all models
Followers
4
Attributed to Hugging Face organization "Commure, Inc." as of 2026-09-18. Open-weights footprint only — closed-model usage is not publicly measurable. Verify on Hugging Face ↗
Talent Signal
Hiring trend
▶ Hiring steady
+5% vs 2026-08
Open roles
80
via ashby
Product-build share
55%
engineering, research, product, design
Trajectory
steady
product-led hiring — 55% of open roles build product; the rest are go-to-market and G&A.
Counted from Commure's live job board as of 2026-09-15; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Products
Healthcare operations platform
Ambient clinical documentation
Competitors
Abridge · Innovaccer · Epic Systems
HealthcareAIHealth IT
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2024. Refreshed quarterly.